| Name | Title | Contact Details |
|---|
Deaconess HomeCare is a Hattiesburg, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.
Prospect Medical Holdings, Inc. is a leading provider of healthcare services comprised of 22 hospitals and over 140 primary and specialty care clinics located throughout Southern California, South Central Texas, Rhode Island, New Jersey, Connecticut, and Pennsylvania. Established in 1996, Prospect Medical Holdings, Inc. has grown into a significant provider of coordinated regional healthcare services throughout Southern California, South Central Texas, Rhode Island, New Jersey, Connecticut, and Pennsylvania. We were among the first healthcare providers in the country to adopt an operating model, termed Coordinated-Regional-Care, that prefigures the objectives of the Affordable Care Act – to improve quality, reduce cost and enhance overall patient care. Our comprehensive network aims to provide coordinated, personalized care. We specialize in building comprehensive networks of quality healthcare services designed to meet the needs of our patients and members. Our goal is always to ensure high-quality outcomes. Above all, we are committed to quality in all aspects of healthcare delivery, including: 1. Striving for the best possible patient outcomes 2. Maintaining the highest standards of patient safety 3. Acting with integrity at all times 4. Promoting open communication 5. Collaborating to better serve the healthcare needs of our communities
Barnabas Health provides treatment and services for more than two million patients each year: 198,000 inpatients and Same Day Surgery patients; 452,000 Emergency Department patients; and 1.5 million outpatients; and delivers more than 18,300 babies annually. Our 18,200 employees, 4,600 physicians and 445 residents and interns are united in our mission to deliver the highest quality of care in the best possible environment. Among our nationally renowned services are: New Jersey’s only certified burn treatment facility, world-class cardiac surgery services for adults; the oldest, most experienced heart transplant program in New Jersey ranked by volume in the top 10 in the nation; the only lung transplant program in New Jersey; one of the country’s most comprehensive robotic surgery services, six nationally certified chest pain centers; accredited certified comprehensive and primary stroke centers, two kidney transplant centers which are in the top 10 of 240 programs in the country; a renowned neurology and neurosurgery program; highly respected assistive reproductive technology program; comprehensive cancer services for adults and children; nationally recognized geriatric services and renowned women’s and children’s services. Throughout Barnabas Health, our dedicated physicians, nurses and health professionals are committed to providing the highest quality of patient care and health education to the community and the region.
Interface People is a Lewisville, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.